<table id="tablei" stylecode="Noautorules" width="600" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table I. Mean and range of total body clearance and half-life of theophylline related to age and altered physiological states.*</caption>
<col align="left" width="50%"></col>
<col align="left" width="25%"></col>
<col align="left" width="25%"></col>
<thead>
<tr stylecode="Toprule Botrule">
<th valign="bottom">Population characteristics</th>
<th align="center">Total body
														<br/>clearance†
														<br/>mean (range) ǂ
														<br/>(mL/kg/min)</th>
<th align="center">Half-life Mean
														<br/>(range) ǂ
														<br/>(hr)</th>
</tr>
</thead>
<tfoot>
<tr stylecode="Botrule">
<td colspan="3">*    For various North American patient populations from literature reports. Different rates of
														<br/>      elimination and consequent dosage requirements have been observed among other peoples.
														<br/>†    Clearance represents the volume of blood completely cleared of theophylline by the liver in
														<br/>      one minute. Values listed were generally determined at serum theophylline concentrations
														<br/>      &lt;20 mcg/mL; clearance may decrease and half-life may increase at higher serum
														<br/>      concentrations due to non-linear pharmacokinetics.
														<br/>ǂ     Reported range or estimated range (mean ± 2 SD) where actual range not reported.
														<br/>§    NR =not reported or not reported in a comparable format.
														<br/>¶    Median
														<br/>
<content stylecode="bold">Note:</content>  In addition to the factors listed above, theophylline clearance is increased and
														<br/>half-life decreased by low carbohydrate/high protein diets, parenteral nutrition, and
														<br/>daily consumption of charcoal-broiled beef. A high carbohydrate/low protein diet can
														<br/>decrease the clearance and prolong the half-life of theophylline.</td>
</tr>
</tfoot>
<tbody>
<tr valign="bottom">
<td>
<content stylecode="bold underline">Age</content>
</td>
<td></td>
<td></td>
</tr>
<tr valign="bottom">
<td>Premature neonates</td>
<td></td>
<td></td>
</tr>
<tr valign="bottom">
<td>   postnatal age 3 - 15 days</td>
<td>0.29 (0.09 - 0.49)</td>
<td>30 (17 - 43)</td>
</tr>
<tr valign="bottom">
<td>   postnatal age 25 - 57 days</td>
<td>0.64 (0.04 - 1.2)</td>
<td>20 (9.4 - 30.6)</td>
</tr>
<tr valign="bottom">
<td>Term infants</td>
<td></td>
<td></td>
</tr>
<tr valign="bottom">
<td>   postnatal age 1 - 2 days</td>
<td>NR §</td>
<td>25.7 (25 - 26.5)</td>
</tr>
<tr valign="bottom">
<td>   postnatal age 3 - 30 weeks</td>
<td>NR §</td>
<td>11 (6 - 29)</td>
</tr>
<tr valign="bottom">
<td>Children</td>
<td></td>
<td></td>
</tr>
<tr valign="bottom">
<td>   1 - 4 years</td>
<td>1.7 (0.5 - 2.9)</td>
<td>3.4 (1.2 - 5.6)</td>
</tr>
<tr valign="bottom">
<td>   4 - 12 years</td>
<td>1.6 (0.8 - 2.4)</td>
<td>NR §</td>
</tr>
<tr valign="bottom">
<td>   13 - 15 years</td>
<td>0.9 (0.48 - 1.3)</td>
<td>NR §</td>
</tr>
<tr valign="bottom">
<td>   6 - 17 years</td>
<td>1.4 (0.2 - 2.6)</td>
<td>3.7 (1.5 - 5.9)</td>
</tr>
<tr valign="bottom">
<td>Adults (16 - 60 years)</td>
<td></td>
<td></td>
</tr>
<tr valign="bottom">
<td>   otherwise healthy non-smoking
														<br/>   asthmatics</td>
<td>0.65 (0.27 - 1.03)</td>
<td>8.7 (6.1 - 12.8)</td>
</tr>
<tr valign="bottom">
<td>Elderly (&gt;60 years)	</td>
<td></td>
<td></td>
</tr>
<tr valign="bottom">
<td>   non-smokers with normal cardiac, liver,
														<br/>   and renal function</td>
<td>0.41 (0.21 - 0.61)</td>
<td>9.8 (1.6 - 18)</td>
</tr>
<tr valign="bottom">
<td colspan="3">
<content stylecode="bold underline">Concurrent illness or altered physiological state</content>
</td>
</tr>
<tr valign="bottom">
<td>Acute pulmonary edema</td>
<td>0.33¶ (0.07 - 2.45)</td>
<td>19¶ (3.1 - 82)</td>
</tr>
<tr valign="bottom">
<td>COPD &gt;60 years, stable	</td>
<td></td>
<td></td>
</tr>
<tr valign="bottom">
<td>   non-smoker &gt;1 year</td>
<td>0.54 (0.44 - 0.64)</td>
<td>11 (9.4 - 12.6)</td>
</tr>
<tr valign="bottom">
<td>COPD with cor-pulmonale</td>
<td>0.48 (0.08 - 0.88)</td>
<td>NR §</td>
</tr>
<tr valign="bottom">
<td>Cystic fibrosis (14 - 28 years)</td>
<td>1.25 (0.31 - 2.2)</td>
<td>6.0 (1.8 - 10.2)</td>
</tr>
<tr valign="bottom">
<td>Fever associated with acute viral</td>
<td></td>
<td></td>
</tr>
<tr valign="bottom">
<td>   respiratory illness (children 9 - 15 years)</td>
<td>NR §</td>
<td>7.0 (1.0 - 13)</td>
</tr>
<tr valign="bottom">
<td>Liver disease –       cirrhosis</td>
<td>0.31¶ (0.1 - 0.7)</td>
<td>32¶ (10 - 56)</td>
</tr>
<tr valign="bottom">
<td align="left">                              acute hepatitis</td>
<td>0.35 (0.25 - 0.45)</td>
<td>19.2 (16.6 - 21.8)</td>
</tr>
<tr valign="bottom">
<td align="left">                              cholestasis</td>
<td>0.65 (0.25 - 1.45)</td>
<td>14.4 (5.7 - 31.8)</td>
</tr>
<tr valign="bottom">
<td>Pregnancy –           1st trimester</td>
<td>NR §</td>
<td>8.5 (3.1 - 13.9)</td>
</tr>
<tr valign="bottom">
<td>                              2nd trimester</td>
<td>NR §</td>
<td>8.8 (3.8 - 13.8)</td>
</tr>
<tr valign="bottom">
<td>                              3rd trimester</td>
<td>NR §</td>
<td>13.0 (8.4 - 17.6)</td>
</tr>
<tr valign="bottom">
<td>Sepsis with multi-organ failure</td>
<td>0.47 (0.19 - 1.9)</td>
<td>18.8 (6.3 - 24.1)</td>
</tr>
<tr valign="bottom">
<td>Thyroid disease –   hypothyroid</td>
<td>0.38 (0.13 - 0.57)</td>
<td>11.6 (8.2 - 25)</td>
</tr>
<tr stylecode="Botrule" valign="bottom">
<td>                              hyperthyroid</td>
<td>0.8 (0.68 - 0.97)</td>
<td>4.5 (3.7 - 5.6)</td>
</tr>
</tbody>
</table>